CRYP:AU:AU-BetaShares Crypto Innovators ETF (AUD)

ETF | Others |

Last Closing

USD 7.31

Change

-0.22 (-2.92)%

Market Cap

N/A

Volume

0.15M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.18 (+0.18%)

USD 16.85B
IVV:AU iShares Core S&P 500 AUD

+0.41 (+0.64%)

USD 9.99B
VGS:AU Vanguard MSCI International Sh..

+0.91 (+0.65%)

USD 9.45B
QUAL:AU VanEck Vectors MSCI World ex A..

+0.29 (+0.50%)

USD 6.99B
IOZ:AU Ishares Core S&P/Asx 200

+0.10 (+0.30%)

USD 6.22B
STW:AU SPDR® S&P/ASX 200 Fund

+0.21 (+0.28%)

USD 5.69B
NDQ:AU Betashares Nasdaq 100

+0.41 (+0.80%)

USD 5.22B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

+0.12 (+0.28%)

USD 4.86B
A200:AU BetaShares Australia 200

+0.30 (+0.22%)

USD 4.72B
VTS:AU Vanguard US Total Market Share..

+2.30 (+0.49%)

USD 4.71B

ETFs Containing CRYP:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 46.49% 98% N/A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.49% 97% N/A 88% B+
Trailing 12 Months  
Capital Gain 62.08% 99% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 62.08% 98% N/A 90% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 42.46% 99% N/A 79% B-
Dividend Return 42.46% 99% N/A 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 54.76% 2% F 38% F
Risk Adjusted Return 77.55% 79% B- 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.